OpGen, Inc. is a leading innovator in rapid, accurate genomic and DNA analysis systems and services. The company's Argus Whole Genome Mapping System, GenomeBuilder and MapIt Services provide high resolution, whole genome maps for sequence assembly and finishing, strain typing and comparative genomics in the life sciences market. OpGen's powerful technology dramatically improves the quality of data and time-to results by providing sequence information from single DNA molecules more rapidly and less expensively than previously possible. The company is dedicated to positively influencing individual healthcare outcomes, advancing scientific research and enhancing public health by delivering precise, actionable information and results to customers in the life science and healthcare communities. OpGen's customers include leading genomic research centers, biodefense organizations, academic institutions, clinical research organizations and biotechnology companies.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
03/07/12 | $17,000,000 |
CHL Medical Partners Gcross Creek Capital Harris & Harris Group Highland Capital Partners jVen Capital Versant Ventures | undisclosed |